Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|November 6, 2024
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedulesGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Scientific Reports|July 31, 2024
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing offGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Brain Communications|February 20, 2026
TMS-EEG signatures of motor network dysfunction in multiple sclerosisGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Frontiers in Human Neuroscience|August 30, 2023
Using TMS-EEG to assess the effects of neuromodulation techniques: a narrative reviewAlessandro Cruciani, Marco Mancuso, Valerio Sveva, et al.
Neurobiology of Disease|March 11, 2023
Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEGGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Neurology|February 13, 2026
Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple SclerosisWallace J Brownlee, Davide Maccarrone, Riccardo Nistri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2025
The effects of gamma-tACS on cognitive impairment in multiple sclerosis: A randomized, double-blind, sham-controlled, pilot studyGina Ferrazzano, Davide Maccarrone, Andrea Guerra, et al.
Neurology|March 19, 2026
Resting-State EEG Microstates as Dynamic Biomarkers of Network Dysfunction and Cognitive Impairment in Patients With Multiple SclerosisGiorgio Leodori, Davide Maccarrone, Marco Mancuso, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Pageof 1